Summary

Description

Brookhaven National Laboratory (BNL) on Long Island, New York, has a proven track record of using Positron Emission Tomography (PET) to improve drug discovery and development. BNL is a pioneer and leader in this field, advancing medical imaging technology for over 50 years. BNL's PET Imaging Group has a long history of widely cited investigations of the neurochemical circuits that are disrupted in diseases of addiction and in pathological eating disorders (obesity) as well as working with pharmaceutical and biotech organizations under collaborative arrangements to study various aspects of drug development. If you are developing a new drug or studying new uses of an old drug and need information on mechanisms, sites of action, dosing amounts, dosing schedules, and/or possible side effects, BNL's PET Imaging Group can help you get the results you need.